{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:36:18Z","timestamp":1790616978803,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T00:00:00Z","timestamp":1501804800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007394","name":"Instituto Nacional de Ci\u00eancia e Tecnologia de Ci\u00eancia Animal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007394","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10787-017-0383-7","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T09:52:17Z","timestamp":1501840337000},"page":"491-504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2002-9826","authenticated-orcid":false,"given":"Felipe","family":"Grabarz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristhiane Favero","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus","family":"Correa-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e1rcio Teodoro","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meire I.","family":"Hyane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcius","family":"Andrade-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maristella Almeida","family":"Landgraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels Olsen Saraiva","family":"C\u00e2mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,4]]},"reference":[{"key":"383_CR1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.smim.2014.06.003","volume":"26","author":"JE Allen","year":"2014","unstructured":"Allen JE, Sutherland TE (2014) Host protective roles of type 2 immunity: parasite killing and tissue repair, flip sides of the same coin. Semin Immunol 26:329\u2013340","journal-title":"Semin Immunol"},{"key":"383_CR2","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.4049\/jimmunol.179.8.5126","volume":"179","author":"E Ambrosino","year":"2007","unstructured":"Ambrosino E, Terabe M, Halder RC et al (2007) Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis. J Immunol 179:5126\u20135136. doi:\n                        10.4049\/jimmunol.179.8.5126","journal-title":"J Immunol"},{"key":"383_CR3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","volume":"161","author":"American Thoracic Society","year":"2000","unstructured":"American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. Am J Respir Crit Care Med 161:646\u2013664","journal-title":"Am J Respir Crit Care Med"},{"key":"383_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1053\/j.gastro.2010.10.003","volume":"140","author":"P Arrenberg","year":"2011","unstructured":"Arrenberg P, Maricic I, Kumar V (2011) Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice. Gastroenterology 140:646\u2013655. doi:\n                        10.1053\/j.gastro.2010.10.003","journal-title":"Gastroenterology"},{"key":"383_CR5","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1038\/emboj.2011.145","volume":"30","author":"S Aspeslagh","year":"2011","unstructured":"Aspeslagh S, Li Y, Yu ED et al (2011) Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis. EMBO J 30:2294\u20132305. doi:\n                        10.1038\/emboj.2011.145","journal-title":"EMBO J"},{"key":"383_CR6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/156652409788970706","volume":"9","author":"JA Berzofsky","year":"2009","unstructured":"Berzofsky JA, Terabe M (2009) The contrasting roles of NKT cells in tumor immunity. Curr Mol Med 9:667\u2013672","journal-title":"Curr Mol Med"},{"key":"383_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3109\/08977194.2011.595714","volume":"29","author":"A Biernacka","year":"2011","unstructured":"Biernacka A, Dobaczewski M, Frangogiannis NG (2011) TGF-\u03b2 signaling in fibrosis. Growth Factors 29:196\u2013202. doi:\n                        10.3109\/08977194.2011.595714","journal-title":"Growth Factors"},{"key":"383_CR8","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<2014::AID-IMMU2014>3.0.CO;2-G","volume":"29","author":"N Burdin","year":"1999","unstructured":"Burdin N, Brossay L, Kronenberg M (1999) Immunization with alpha-galactosylceramide polarizes CD1-reactive NKT cells towards Th2 cytokine synthesis. Eur J Immunol 29:2014\u20132025","journal-title":"Eur J Immunol"},{"key":"383_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2217\/imt.13.175","volume":"6","author":"LJ Carre\u00f1o","year":"2014","unstructured":"Carre\u00f1o LJ, Kharkwal SS, Porcelli SA (2014) Optimizing NKT cell ligands as vaccine adjuvants. Immunotherapy 6:309\u2013320. doi:\n                        10.2217\/imt.13.175","journal-title":"Immunotherapy"},{"key":"383_CR10","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1100\/2011\/213962","volume":"11","author":"L Cassetta","year":"2011","unstructured":"Cassetta L, Cassol E, Poli G (2011) Macrophage polarization in health and disease. Sci World J 11:2391\u20132402. doi:\n                        10.1100\/2011\/213962","journal-title":"Sci World J"},{"key":"383_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1165\/rcmb.2005-0062TR","volume":"33","author":"F Chua","year":"2005","unstructured":"Chua F, Gauldie J, Laurent GJ (2005) Pulmonary fibrosis: searching for model answers. Am J Respir Cell Mol Biol 33:9\u201313","journal-title":"Am J Respir Cell Mol Biol"},{"key":"383_CR12","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1183\/09031936.98.11061218","volume":"11","author":"RK Coker","year":"1998","unstructured":"Coker RK, Laurent GJ (1998) Pulmonary fibrosis: cytokines in the balance. Eur Respir J 11:1218\u20131221","journal-title":"Eur Respir J"},{"key":"383_CR13","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1126\/science.278.5343.1623","volume":"278","author":"J Cui","year":"1997","unstructured":"Cui J, Shin T, Kawano T et al (1997) Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278:1623\u20131626. doi:\n                        10.1126\/science.278.5343.1623","journal-title":"Science"},{"key":"383_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/med.21276","volume":"34","author":"JE East","year":"2014","unstructured":"East JE, Kennedy AJ, Webb TJ (2014) Raising the roof: the preferential pharmacological stimulation of Th1 and Th2 responses mediated by NKT cells. Med Res Rev 34:45\u201376. doi:\n                        10.1002\/med.21276","journal-title":"Med Res Rev"},{"key":"383_CR15","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1172\/JCI19836","volume":"113","author":"IJ Fuss","year":"2004","unstructured":"Fuss IJ, Heller F, Boirivant M et al (2004) Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 113:1490\u20131497. doi:\n                        10.1172\/JCI19836","journal-title":"J Clin Invest"},{"key":"383_CR16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.bbadis.2012.09.008","volume":"1832","author":"B Gao","year":"2013","unstructured":"Gao B, Radaeva S (2013) Natural killer and natural killer T cells in liver fibrosis. Biochim Biophys Acta Mol Basis Dis 1832:1061\u20131069. doi:\n                        10.1016\/j.bbadis.2012.09.008","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"383_CR17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jlb.64.5.657","volume":"64","author":"M Gharaee-Kermani","year":"1998","unstructured":"Gharaee-Kermani M, McGarry B, Lukacs N et al (1998) The role of IL-5 in bleomycin-induced pulmonary fibrosis. J Leukoc Biol 64:657\u2013666","journal-title":"J Leukoc Biol"},{"key":"383_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1006\/cyto.2001.0903","volume":"15","author":"M Gharaee-Kermani","year":"2001","unstructured":"Gharaee-Kermani M, Nozaki Y, Hatano K, Phan SH (2001) Lung interleukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis. Cytokine 15:138\u2013147. doi:\n                        10.1006\/cyto.2001.0903","journal-title":"Cytokine"},{"key":"383_CR19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","volume":"32","author":"S Gordon","year":"2010","unstructured":"Gordon S, Martinez FO (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32:593\u2013604","journal-title":"Immunity"},{"key":"383_CR20","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1172\/JCI31602","volume":"117","author":"RC Halder","year":"2007","unstructured":"Halder RC, Aguilera C, Maricic I, Kumar V (2007) Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease. J Clin Invest 117:2302\u20132312. doi:\n                        10.1172\/JCI31602","journal-title":"J Clin Invest"},{"key":"383_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jbior.2014.09.008","volume":"57","author":"LS Huang","year":"2015","unstructured":"Huang LS, Natarajan V (2015) Sphingolipids in pulmonary fibrosis. Adv Biol Regul 57:55\u201363. doi:\n                        10.1016\/j.jbior.2014.09.008","journal-title":"Adv Biol Regul"},{"key":"383_CR22","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1084\/jem.20031389","volume":"199","author":"A Jahng","year":"2004","unstructured":"Jahng A, Maricic I, Aguilera C et al (2004) Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J Exp Med 199:947\u2013957. doi:\n                        10.1084\/jem.20031389","journal-title":"J Exp Med"},{"key":"383_CR23","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0002-9440(10)61211-4","volume":"167","author":"JH Kim","year":"2005","unstructured":"Kim JH, Kim HY, Kim S et al (2005) Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma. Am J Pathol 167:1231\u20131241","journal-title":"Am J Pathol"},{"key":"383_CR24","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.4049\/jimmunol.172.9.5782","volume":"172","author":"T Kimura","year":"2004","unstructured":"Kimura T, Ishii Y, Morishima Y et al (2004) Treatment with alpha-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis. J Immunol 172:5782\u20135789","journal-title":"J Immunol"},{"key":"383_CR25","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jhep.2013.02.032","volume":"59","author":"V Kumar","year":"2013","unstructured":"Kumar V (2013) NKT-cell subsets: promoters and protectors in inflammatory liver disease. J Hepatol 59:618\u2013620. doi:\n                        10.1016\/j.jhep.2013.02.032","journal-title":"J Hepatol"},{"key":"383_CR26","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1084\/jem.194.6.809","volume":"194","author":"CG Lee","year":"2001","unstructured":"Lee CG, Homer RJ, Zhu Z et al (2001) Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med 194:809\u2013821. doi:\n                        10.1084\/jem.194.6.809","journal-title":"J Exp Med"},{"key":"383_CR27","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1097\/MIB.0b013e318280b1e3","volume":"19","author":"C-M Liao","year":"2013","unstructured":"Liao C-M, Zimmer MI, Wang C-R (2013) The functions of type I and type II natural killer T cells in inflammatory bowel diseases. Inflamm Bowel Dis 19:1330\u20131338. doi:\n                        10.1097\/MIB.0b013e318280b1e3","journal-title":"Inflamm Bowel Dis"},{"key":"383_CR28","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1002\/eji.201242433","volume":"42","author":"E Maier","year":"2012","unstructured":"Maier E, Duschl A, Horejs-Hoeck J (2012) STAT6-dependent and -independent mechanisms in Th2 polarization. Eur J Immunol 42:2827\u20132833. doi:\n                        10.1002\/eji.201242433","journal-title":"Eur J Immunol"},{"key":"383_CR29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fimmu.2015.00316","volume":"6","author":"I Marrero","year":"2015","unstructured":"Marrero I, Ware R, Kumar V (2015) Type II NKT cells in inflammation, autoimmunity, microbial immunity, and cancer. Front Immunol 6:316. doi:\n                        10.3389\/fimmu.2015.00316","journal-title":"Front Immunol"},{"key":"383_CR30","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1002\/hep.27392","volume":"60","author":"A Mitra","year":"2014","unstructured":"Mitra A, Satelli A, Yan J et al (2014) IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in mice. Hepatology 60:2027\u20132039. doi:\n                        10.1002\/hep.27392","journal-title":"Hepatology"},{"key":"383_CR31","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/35097097","volume":"413","author":"K Miyamoto","year":"2001","unstructured":"Miyamoto K, Miyake S, Yamamura T (2001) A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413:531\u2013534. doi:\n                        10.1038\/35097097","journal-title":"Nature"},{"key":"383_CR32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1089\/jir.2011.0027","volume":"31","author":"AP Moreira","year":"2011","unstructured":"Moreira AP, Hogaboam CM (2011) Macrophages in allergic asthma: fine-tuning their pro- and anti-inflammatory actions for disease resolution. J Interferon Cytokine Res 31:485\u2013491. doi:\n                        10.1089\/jir.2011.0027","journal-title":"J Interferon Cytokine Res"},{"key":"383_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009683","author":"LA Murray","year":"2010","unstructured":"Murray LA, Rosada R, Moreira AP et al (2010) Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages. PLoS One. doi:\n                        10.1371\/journal.pone.0009683","journal-title":"PLoS One"},{"key":"383_CR34","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1021\/ci8002705","volume":"49","author":"J Nadas","year":"2009","unstructured":"Nadas J, Li C, Wang PG (2009) Computational structure activity relationship studies on the CD1d\/glycolipid\/TCR complex using AMBER and AUTODOCK. J Chem Inf Model 49:410\u2013423. doi:\n                        10.1021\/ci8002705","journal-title":"J Chem Inf Model"},{"key":"383_CR35","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1189\/jlb.1012512","volume":"93","author":"ML Novak","year":"2013","unstructured":"Novak ML, Koh TJ (2013) Macrophage phenotypes during tissue repair. J Leukoc Biol 93:875\u2013881. doi:\n                        10.1189\/jlb.1012512","journal-title":"J Leukoc Biol"},{"key":"383_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1667\/RR13581.1","volume":"181","author":"A Paun","year":"2014","unstructured":"Paun A, Bergeron M-E, Haston CK (2014) NKT deficient mice are not spared lung disease after exposure to thoracic radiotherapy. Radiat Res 181:369\u2013375. doi:\n                        10.1667\/RR13581.1","journal-title":"Radiat Res"},{"key":"383_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clim.2010.06.017","volume":"137","author":"DV Pechkovsky","year":"2010","unstructured":"Pechkovsky DV, Prasse A, Kollert F et al (2010) Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clin Immunol 137:89\u2013101. doi:\n                        10.1016\/j.clim.2010.06.017","journal-title":"Clin Immunol"},{"key":"383_CR38","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1172\/JCI36150","volume":"118","author":"SD Ricardo","year":"2008","unstructured":"Ricardo SD, Van Goor H, Eddy AA (2008) Macrophage diversity in renal injury and repair. J Clin Invest 118:3522\u20133530","journal-title":"J Clin Invest"},{"key":"383_CR39","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1084\/jem.20031192","volume":"198","author":"J Schmieg","year":"2003","unstructured":"Schmieg J, Yang G, Franck RW, Tsuji M (2003) Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand \u03b1-galactosylceramide. J Exp Med 198:1631\u20131641. doi:\n                        10.1084\/jem.20031192","journal-title":"J Exp Med"},{"key":"383_CR40","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/82698","volume":"1","author":"MJ Smyth","year":"2000","unstructured":"Smyth MJ, Godfrey DI (2000) NKT cells and tumor immunity\u2014a double-edged sword. Nat Immunol 1:459\u2013460. doi:\n                        10.1038\/82698","journal-title":"Nat Immunol"},{"key":"383_CR41","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.5966\/sctm.2015-0121","volume":"4","author":"N Srour","year":"2015","unstructured":"Srour N, Th\u00e9baud B (2015) Mesenchymal stromal cells in animal bleomycin pulmonary fibrosis models: a systematic review. Stem Cells Transl Med 4:1500\u20131510. doi:\n                        10.5966\/sctm.2015-0121","journal-title":"Stem Cells Transl Med"},{"key":"383_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081382","author":"M Stahl","year":"2013","unstructured":"Stahl M, Schupp J, J\u00e4ger B et al (2013) Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation. PLoS One. doi:\n                        10.1371\/journal.pone.0081382","journal-title":"PLoS One"},{"key":"383_CR43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1172\/JCI22398","volume":"114","author":"RM Strieter","year":"2004","unstructured":"Strieter RM, Keane MP (2004) Innate immunity dictates cytokine polarization relevant to the development of pulmonary fibrosis. J Clin Invest 114:165\u2013168","journal-title":"J Clin Invest"},{"key":"383_CR44","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1136\/gutjnl-2011-301857","volume":"61","author":"W-K Syn","year":"2012","unstructured":"Syn W-K, Agboola KM, Swiderska M et al (2012) NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease. Gut 61:1323\u20131329. doi:\n                        10.1136\/gutjnl-2011-301857","journal-title":"Gut"},{"key":"383_CR45","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.immuni.2006.04.009","volume":"24","author":"S Tanaka","year":"2006","unstructured":"Tanaka S, Tsukada J, Suzuki W et al (2006) The interleukin-4 enhancer CNS-2 is regulated by notch signals and controls initial expression in NKT cells and memory-type CD4 T cells. Immunity 24:689\u2013701. doi:\n                        10.1016\/j.immuni.2006.04.009","journal-title":"Immunity"},{"key":"383_CR46","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0065-230X(08)00408-9","volume":"101","author":"M Terabe","year":"2008","unstructured":"Terabe M, Berzofsky JA (2008) The role of NKT cells in tumor immunity. Adv Cancer Res 101:277\u2013348. doi:\n                        10.1016\/S0065-230X(08)00408-9","journal-title":"Adv Cancer Res"},{"key":"383_CR47","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.2353\/ajpath.2008.070832","volume":"172","author":"G Trujillo","year":"2008","unstructured":"Trujillo G, O\u2019Connor EC, Kunkel SL, Hogaboam CM (2008) A novel mechanism for CCR4 in the regulation of macrophage activation in bleomycin-induced pulmonary fibrosis. Am J Pathol 172:1209\u20131221. doi:\n                        10.2353\/ajpath.2008.070832","journal-title":"Am J Pathol"},{"key":"383_CR48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1385\/IR:30:2:139","volume":"30","author":"L Kaer Van","year":"2004","unstructured":"Van Kaer L (2004) Regulation of immune responses by CD1d-restricted natural killer T cells. Immunol Res 30:139\u2013153. doi:\n                        10.1385\/IR:30:2:139","journal-title":"Immunol Res"},{"key":"383_CR49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00441-010-1023-3","volume":"343","author":"L Kaer Van","year":"2011","unstructured":"Van Kaer L, Parekh VV, Wu L (2011) Invariant natural killer T cells: bridging innate and adaptive immunity. Cell Tissue Res 343:43\u201355","journal-title":"Cell Tissue Res"},{"key":"383_CR50","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.imbio.2008.11.009","volume":"214","author":"A Varin","year":"2009","unstructured":"Varin A, Gordon S (2009) Alternative activation of macrophages: immune function and cellular biology. Immunobiology 214:630\u2013641. doi:\n                        10.1016\/j.imbio.2008.11.009","journal-title":"Immunobiology"},{"key":"383_CR51","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nri1412","volume":"4","author":"Ta Wynn","year":"2004","unstructured":"Wynn Ta (2004) Fibrotic disease and the T(H)1\/T(H)2 paradigm. Nat Rev Immunol 4:583\u2013594. doi:\n                        10.1038\/nri1412","journal-title":"Nat Rev Immunol"},{"key":"383_CR52","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.intimp.2016.04.016","volume":"36","author":"J Xiang","year":"2016","unstructured":"Xiang J, Cheng S, Feng T et al (2016) Neotuberostemonine attenuates bleomycin-induced pulmonary fibrosis by suppressing the recruitment and activation of macrophages. Int Immunopharmacol 36:158\u2013164. doi:\n                        10.1016\/j.intimp.2016.04.016","journal-title":"Int Immunopharmacol"},{"key":"383_CR53","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1681\/ASN.2010080815","volume":"22","author":"SH Yang","year":"2011","unstructured":"Yang SH, Lee JP, Jang HR et al (2011) Sulfatide-reactive natural killer T cells abrogate ischemia-reperfusion injury. J Am Soc Nephrol 22:1305\u20131314. doi:\n                        10.1681\/ASN.2010080815","journal-title":"J Am Soc Nephrol"},{"key":"383_CR54","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000109195","volume":"5","author":"K Zhang","year":"1996","unstructured":"Zhang K, Phan SH (1996) Cytokines and pulmonary fibrosis. Biol Signals 5:232\u2013239","journal-title":"Biol Signals"},{"key":"383_CR55","first-page":"192","volume":"70","author":"K Zhang","year":"1994","unstructured":"Zhang K, Gharaee-Kermani M, McGarry B, Phan SH (1994) In situ hybridization analysis of rat lung alpha 1(I) and alpha 2(I) collagen gene expression in pulmonary fibrosis induced by endotracheal bleomycin injection. Lab Invest 70:192\u2013202","journal-title":"Lab Invest"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-017-0383-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-017-0383-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-017-0383-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T06:00:47Z","timestamp":1521439247000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-017-0383-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,4]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["383"],"URL":"https:\/\/doi.org\/10.1007\/s10787-017-0383-7","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,4]]}}}